What did @haleighweaver5 actually say?
Honestly, this one is tricky to fact-check in the traditional sense. The creator's spoken transcript is incoherent audio, likely a song or heavily distorted audio capture, not a medical claim. What we do have is the caption, where she says she started "zempic" (almost certainly Ozempic, the brand name for semaglutide) and is feeling better "mentally and physically." The hashtags tell a clearer story: PCOS, insulin resistance, GLP-1, and weight loss surgery community tags all together suggest she's using semaglutide off-label for polycystic ovary syndrome management. That context matters a lot.
Because the spoken content is not analyzable, this fact-check focuses on the claims embedded in her caption and hashtag framing. She is implying that a GLP-1 receptor agonist improved her quality of life in the context of PCOS, and that framing deserves scrutiny on its own terms.
Does the science back this up?
For PCOS and insulin resistance specifically, the evidence for GLP-1 receptor agonists is actually pretty promising, though not yet a clean slam dunk. Several trials support the general direction she's pointing.
A 2022 randomized controlled trial by Elkind-Hirsch et al., published in Fertility and Sterility, found that liraglutide (a GLP-1 agonist closely related to semaglutide) improved menstrual regularity, reduced androgen levels, and improved insulin sensitivity in women with PCOS and obesity. A 2023 meta-analysis by Xiao et al. in Frontiers in Endocrinology looked at multiple GLP-1 agents in PCOS populations and found consistent improvements in BMI, fasting insulin, and HOMA-IR scores across studies.
The mental health angle she mentions, feeling better "mentally," is less well-studied but not without basis. A 2023 paper by Mansur et al. in CNS Drugs reviewed emerging evidence that GLP-1 receptors in the brain may influence mood and anxiety pathways, though this remains preliminary and is not an approved indication for any GLP-1 drug.
- GLP-1 agonists show real benefit for insulin resistance in PCOS populations
- Weight loss from these drugs can reduce androgen excess in PCOS
- Mental health improvements may reflect better overall metabolic health, not a direct brain effect
What did they get wrong (or right)?
She got the general direction right. Using a GLP-1 receptor agonist when you have PCOS and insulin resistance is not a fringe or reckless choice. It's actually a reasonable off-label use that many endocrinologists and OB-GYNs are increasingly comfortable with, even though the FDA has not approved semaglutide specifically for PCOS.
What she did not address, and what is worth noting for the 35,000-plus people who saw this video, is that "feeling good" is not the same as treating the underlying condition. PCOS is a complex hormonal disorder. GLP-1 drugs address some downstream effects of insulin resistance but do not normalize ovarian function for everyone, do not guarantee fertility outcomes, and are not a permanent fix if the drug is stopped. The weight loss surgery community hashtags also add a layer of complexity. Some people in that community use GLP-1 drugs post-bariatric surgery for weight regain, which is a different clinical situation than primary PCOS management.
No dangerous claims were made. No doses were suggested. No cures were promised. That puts her ahead of a lot of GLP-1 content on TikTok.
What should you actually know?
If you have PCOS and are considering a GLP-1 receptor agonist, the evidence suggests it can help with insulin resistance, weight, and possibly menstrual regularity. But the research is still catching up to the hype, and not every person with PCOS is the same candidate for this class of drug.
A few things the caption does not tell you: semaglutide is not FDA-approved for PCOS, meaning any prescription for that purpose is off-label. That is legal and common, but it means your prescriber needs to be informed about your full hormonal picture, not just your weight. Also, if you are using a GLP-1 drug and have any interest in becoming pregnant, this requires a specific conversation with your provider. GLP-1 drugs are not recommended during pregnancy, and the washout period matters.
- GLP-1 drugs are off-label for PCOS but are increasingly used in clinical practice
- Benefits in PCOS populations include improved insulin sensitivity and potential androgen reduction
- Mental health improvements are plausible but not a proven direct mechanism of the drug
- Stopping the medication often reverses metabolic improvements over time
- Anyone with PCOS considering pregnancy should discuss GLP-1 use explicitly with their provider